Yao-Wei Huang Selected Research

Yao-Wei Huang Research Topics

Disease

26	Infections 04/2024 - 01/2011
3	Virus Diseases (Viral Diseases) 05/2024 - 12/2022
3	Diarrhea 03/2024 - 01/2021
3	Viremia 06/2012 - 01/2011
2	COVID-19 05/2024 - 01/2023
2	Severe Acute Respiratory Syndrome 01/2021 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2015 - 01/2011
1	Dysbiosis 05/2024
1	Inflammation (Inflammations) 05/2024
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 04/2024
1	Vesicular Stomatitis 04/2024
1	Hyperglycemia 12/2022
1	Mumps 06/2021
1	Coronavirus Infections 01/2021
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2021
1	Measles 01/2018

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2015
5	Antiviral Agents (Antivirals)IBA 05/2024 - 01/2021
5	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2011
4	VaccinesIBA 01/2022 - 01/2018
4	AntibodiesIBA 08/2021 - 10/2014
3	Neutralizing AntibodiesIBA 03/2024 - 09/2019
2	Green Fluorescent ProteinsIBA 04/2024 - 08/2021
2	Complementary DNA (cDNA)IBA 03/2024 - 11/2014
2	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2018
2	EnzymesIBA 03/2022 - 10/2012
2	ImmunosorbentsIBA 03/2022 - 10/2012
2	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2022 - 11/2021
2	Peptides (Polypeptides)IBA 01/2022 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2019 - 07/2011
1	16S Ribosomal RNAIBA 05/2024
1	fucoidanIBA 05/2024
1	CytokinesIBA 05/2024
1	Interferon-betaIBA 04/2024
1	bafilomycin A1IBA 04/2024
1	leu-13 antigenIBA 04/2024
1	IFIH1 Interferon-Induced HelicaseIBA 04/2024
1	Monoclonal AntibodiesIBA 04/2024
1	Chloroquine (Aralen)FDA LinkGeneric 04/2024
1	gamma-Aminobutyric Acid (GABA)IBA 04/2024
1	InterferonsIBA 04/2024
1	Ligases (Synthetase)IBA 04/2024
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 04/2024
1	Phosphotransferases (Kinase)IBA 04/2024
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 04/2024
1	Pattern Recognition ReceptorsIBA 04/2024
1	Peptide Hydrolases (Proteases)FDA Link 03/2024
1	Serine Proteases (Serine Protease)IBA 03/2024
1	Immune Sera (Antisera)IBA 03/2024
1	Glycoproteins (Glycoprotein)IBA 03/2024
1	FurinIBA 03/2024
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 12/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2022
1	Cholic AcidIBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	MannansIBA 08/2021
1	Galactose (Galactopyranose)FDA LinkGeneric 08/2021
1	LectinsIBA 08/2021
1	C-Type Lectins (C-Type Lectin)IBA 08/2021
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 08/2021
1	Attenuated VaccinesIBA 06/2021
1	Two-Pore ChannelsIBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 09/2019
1	Neuraminidase (Sialidase)IBA 01/2018
1	lactate dehydrogenase 1 (LDH1)IBA 07/2015
1	Galectin 1 (LGALS1)IBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 07/2015
1	anti-IgGIBA 10/2014
1	AntigensIBA 10/2012
1	Genetic Markers (Genetic Marker)IBA 06/2012
1	Viral DNAIBA 06/2012
1	DNA (Deoxyribonucleic Acid)IBA 06/2012
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2011

Therapy/Procedure

1	Personal Protective Equipment 01/2023
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Therapeutics 01/2021
1	Electrodes (Electrode) 01/2011